3 | 2 | | *ANS167* 03-16-2023 15:14:00 ANS167 |
---|
4 | 3 | | |
---|
5 | 4 | | State of Arkansas As Engrossed: H3/6/23 H3/9/23 S3/16/23 1 |
---|
6 | 5 | | 94th General Assembly A Bill 2 |
---|
7 | 6 | | Regular Session, 2023 HOUSE BILL 1271 3 |
---|
8 | 7 | | 4 |
---|
9 | 8 | | By: Representatives L. Johnson, Achor, F. Allen, Bentley, Breaux, K. Brown, M. Brown, Joey Carr, 5 |
---|
10 | 9 | | Cavenaugh, Duffield, Ennett, Eubanks, D. Ferguson, V. Flowers, D. Garner, Gramlich, Hawk, G. 6 |
---|
11 | 10 | | Hodges, Hollowell, Ladyman, Long, J. Mayberry, McAlindon, McGrew, B. McKenzie, S. Meeks, J. 7 |
---|
12 | 11 | | Moore, Painter, Pilkington, J. Richardson, R. Scott Richardson, Richmond, Rye, Underwood, Vaught, 8 |
---|
13 | 12 | | Wardlaw, D. Whitaker, Womack, Wooten 9 |
---|
14 | 13 | | By: Senators Irvin, J. Boyd 10 |
---|
15 | 14 | | 11 |
---|
16 | 15 | | For An Act To Be Entitled 12 |
---|
17 | 16 | | AN ACT TO AMEND THE PRIOR AUTHORIZATION TRANSPARENCY 13 |
---|
18 | 17 | | ACT; TO EXEMPT CERTA IN HEALTHCARE PROVID ERS THAT 14 |
---|
19 | 18 | | PROVIDE CERTAIN HEAL THCARE SERVICES FROM PRIOR 15 |
---|
20 | 19 | | AUTHORIZATION REQUIR EMENTS; AND FOR OTHE R PURPOSES. 16 |
---|
21 | 20 | | 17 |
---|
22 | 21 | | 18 |
---|
23 | 22 | | Subtitle 19 |
---|
24 | 23 | | TO AMEND THE PRIOR AUTHORIZATION 20 |
---|
25 | 24 | | TRANSPARENCY ACT; AND TO EXEMPT CERTAIN 21 |
---|
26 | 25 | | HEALTHCARE PROVIDERS THAT PROVIDE CERTAIN 22 |
---|
27 | 26 | | HEALTHCARE SERVICES FROM PRIOR 23 |
---|
28 | 27 | | AUTHORIZATION REQUIREMENTS. 24 |
---|
29 | 28 | | 25 |
---|
30 | 29 | | 26 |
---|
31 | 30 | | BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF ARKANSAS: 27 |
---|
32 | 31 | | 28 |
---|
33 | 32 | | SECTION 1. Arkansas Code § 23-99-1103(8), concerning the definition of 29 |
---|
34 | 33 | | "healthcare insurer" under the Prior Authorization Transparency Act, is 30 |
---|
35 | 34 | | amended to read as follows: 31 |
---|
36 | 35 | | (8)(A)(i) “Healthcare insurer” means an entity that is subject 32 |
---|
37 | 36 | | to state insurance regulation, including an insurance company, a health 33 |
---|
38 | 37 | | maintenance organization, a hospital and medical service corporation, a risk-34 |
---|
39 | 38 | | based provider organization, and a sponsor of a nonfederal self-funded 35 |
---|
40 | 39 | | governmental plan. 36 As Engrossed: H3/6/23 H3/9/23 S3/16/23 HB1271 |
---|
41 | 40 | | |
---|
42 | 41 | | 2 03-16-2023 15:14:00 ANS167 |
---|
43 | 42 | | |
---|
44 | 43 | | |
---|
45 | 44 | | (ii) “Healthcare insurer” includes Medicaid where 1 |
---|
46 | 45 | | specifically referenced in §§ 23-99-1119 — 23-99-1126. 2 |
---|
47 | 46 | | (B) “Healthcare insurer” does not include: 3 |
---|
48 | 47 | | (i) A workers' compensation plan; 4 |
---|
49 | 48 | | (ii) Medicaid, except as provided under §§ 23-99-5 |
---|
50 | 49 | | 1119 — 23-99-1126 or when Medicaid services are managed or reimbursed by a 6 |
---|
51 | 50 | | healthcare insurer; or 7 |
---|
52 | 51 | | (iii) An entity that provides only dental benefits 8 |
---|
53 | 52 | | or eye and vision care benefits; 9 |
---|
54 | 53 | | 10 |
---|
55 | 54 | | SECTION 2. Arkansas Code § 23 -99-1103, concerning definitions used 11 |
---|
56 | 55 | | under the Prior Authorization Transparency Act, is amended to add additional 12 |
---|
57 | 56 | | subdivisions to read as follows: 13 |
---|
58 | 57 | | (22) "Random sample" means at least five (5) claims but no more 14 |
---|
59 | 58 | | than twenty (20) claims for a particular healthcare service that are selected 15 |
---|
60 | 59 | | without method or conscious decision; and 16 |
---|
61 | 60 | | (23) "Value-based reimbursement" means reimbursement that: 17 |
---|
62 | 61 | | (A) Ties a payment for the provision of healthcare 18 |
---|
63 | 62 | | services to the quality of health care provided; 19 |
---|
64 | 63 | | (B) Rewards a healthcare provider for efficiency and 20 |
---|
65 | 64 | | effectiveness; and 21 |
---|
66 | 65 | | (C) May impose a risk -sharing requirement on a healthcare 22 |
---|
67 | 66 | | provider for healthcare services that do not meet the healthcare insurer's 23 |
---|
68 | 67 | | requirements for quality, effectiveness, and efficiency. 24 |
---|
69 | 68 | | 25 |
---|
70 | 69 | | SECTION 3. Arkansas Code § 23 -99-1104(a)(1), concerning disclosure 26 |
---|
71 | 70 | | required under the Prior Au thorization Transparency Act, is amended to read 27 |
---|
72 | 71 | | as follows: 28 |
---|
73 | 72 | | (a)(1)(A) A utilization review entity shall disclose all of its prior 29 |
---|
74 | 73 | | authorization requirements and restrictions, including any written clinical 30 |
---|
75 | 74 | | criteria, in a publicly accessible manner on its website. 31 |
---|
76 | 75 | | (B) The disclosure under subdivision (a)(1)(A) of this 32 |
---|
77 | 76 | | section shall include: 33 |
---|
78 | 77 | | (i) A list of any healthcare services that require 34 |
---|
79 | 78 | | prior authorization; and 35 |
---|
80 | 79 | | (ii) Any written clinical criteria. 36 As Engrossed: H3/6/23 H3/9/23 S3/16/23 HB1271 |
---|
81 | 80 | | |
---|
82 | 81 | | 3 03-16-2023 15:14:00 ANS167 |
---|
83 | 82 | | |
---|
84 | 83 | | |
---|
85 | 84 | | 1 |
---|
86 | 85 | | SECTION 4. Arkansas Code § 23 -99-1111 is amended to read as follows: 2 |
---|
87 | 86 | | 23-99-1111. Requests for prior authorization — Qualified persons 3 |
---|
88 | 87 | | authorized to review and approve — Adverse determinations to be made only by 4 |
---|
89 | 88 | | Arkansas-licensed physicians — Opportunity to discuss treatment before 5 |
---|
90 | 89 | | adverse determination . 6 |
---|
91 | 90 | | (a) The initial review of information submitted in support of a 7 |
---|
92 | 91 | | request for prior authorization may be conducted by a qualified person 8 |
---|
93 | 92 | | employed or contracted by a utilization review entity. 9 |
---|
94 | 93 | | (b) A request for prior authorization may be approved by a qualified 10 |
---|
95 | 94 | | person employed or contracted by a utilization review entity. 11 |
---|
96 | 95 | | (c)(1) An adverse determination regarding a request for prior 12 |
---|
97 | 96 | | authorization shall be made by a physician who possesses a current and 13 |
---|
98 | 97 | | unrestricted license to practice medicine in the State of Arkansas issued by 14 |
---|
99 | 98 | | the Arkansas State Medical Board. 15 |
---|
100 | 99 | | (2)(A) A utilization review entity shall provide a method by 16 |
---|
101 | 100 | | which a physician may request that a prior authorization request be reviewed 17 |
---|
102 | 101 | | by a physician in the same specialty as the physician making the request, by 18 |
---|
103 | 102 | | a physician in another appropriate specialty, or by a pharmacologist. 19 |
---|
104 | 103 | | (B) If a request is made under subdivision (c)(2)(A) of 20 |
---|
105 | 104 | | this section, the reviewing physician or pharmacologist is not required to 21 |
---|
106 | 105 | | meet the requirements of subdivision (c)(1) of this section. 22 |
---|
107 | 106 | | (3)(A) Subject to this subdivision (c)(3), when an adverse 23 |
---|
108 | 107 | | determination is issued by a utilization review entity that questions the 24 |
---|
109 | 108 | | medical necessity, the appropriateness, or the experimental or 25 |
---|
110 | 109 | | investigational nature of a healthcare service, the utilization review entity 26 |
---|
111 | 110 | | shall provide in the notice of adverse determination the name and telephone 27 |
---|
112 | 111 | | number of a physician who possesses a current and unrestricted license i n 28 |
---|
113 | 112 | | this state with whom the requesting healthcare provider may have a reasonable 29 |
---|
114 | 113 | | opportunity to discuss the patient's treatment plan and the clinical basis 30 |
---|
115 | 114 | | for the intervention. 31 |
---|
116 | 115 | | (B) The requesting healthcare provider may contact the 32 |
---|
117 | 116 | | reviewing physician at the telephone number provided with the adverse 33 |
---|
118 | 117 | | determination under subdivision (c)(3)(A) of this section within one (1) 34 |
---|
119 | 118 | | business day of receipt of the adverse determination for an urgent service, 35 |
---|
120 | 119 | | or within two (2) business days of receipt of the adverse determination for a 36 As Engrossed: H3/6/23 H3/9/23 S3/16/23 HB1271 |
---|
121 | 120 | | |
---|
122 | 121 | | 4 03-16-2023 15:14:00 ANS167 |
---|
123 | 122 | | |
---|
124 | 123 | | |
---|
125 | 124 | | nonurgent service, to engage in the discussion of the patient's treatment 1 |
---|
126 | 125 | | plan and the clinical basis for the intervention under subdivision (c)(3)(A) 2 |
---|
127 | 126 | | of this section. 3 |
---|
128 | 127 | | (C)(i) Following any discussion under subdivision 4 |
---|
129 | 128 | | (c)(3)(B) of this section, the utilization review entity shall notify the 5 |
---|
130 | 129 | | healthcare provider whether or not the adverse determination decision remains 6 |
---|
131 | 130 | | the same or the service is approved. 7 |
---|
132 | 131 | | (ii) The notice under subdivision (c)(3)(C)(i) of 8 |
---|
133 | 132 | | this section shall be pro vided: 9 |
---|
134 | 133 | | (a) Within one (1) business day of the 10 |
---|
135 | 134 | | discussion under subdivision (c)(3)(B) of this section between the provider 11 |
---|
136 | 135 | | and physician for an urgent service; or 12 |
---|
137 | 136 | | (b) Within two (2) business days of the 13 |
---|
138 | 137 | | discussion under subdivision (c)(3)(B) of this section between the provider 14 |
---|
139 | 138 | | and physician for a nonurgent service. 15 |
---|
140 | 139 | | (D) A discussion under subdivision (c)(3)(A) of this 16 |
---|
141 | 140 | | section shall not replace or eliminate the opportunity for any internal 17 |
---|
142 | 141 | | grievance or appeal process provided by the utilizatio n review entity. 18 |
---|
143 | 142 | | (E) If a requesting healthcare provider is a physician, 19 |
---|
144 | 143 | | then the reviewing physician with whom the requesting physician is given an 20 |
---|
145 | 144 | | opportunity to discuss the treatment plan and clinical basis for the 21 |
---|
146 | 145 | | intervention under subdivision (c)(3)(B) of this section shall be a physician 22 |
---|
147 | 146 | | who: 23 |
---|
148 | 147 | | (i) Possesses a current and unrestricted 24 |
---|
149 | 148 | | license to practice medicine in this state; and 25 |
---|
150 | 149 | | (ii) Has the same or similar specialty as the 26 |
---|
151 | 150 | | healthcare provider. 27 |
---|
152 | 151 | | 28 |
---|
153 | 152 | | SECTION 5. Arkansas Code Title 23 , Chapter 99, Subchapter 11, is 29 |
---|
154 | 153 | | amended to add additional sections to read as follows: 30 |
---|
155 | 154 | | 23-99-1120. Initial exemption from prior authorization requirements 31 |
---|
156 | 155 | | for healthcare providers providing certain healthcare services. 32 |
---|
157 | 156 | | (a)(1) Except as provided under s ubdivision (a)(2) of this section, 33 |
---|
158 | 157 | | beginning on and after January 1, 2024, a healthcare provider that received 34 |
---|
159 | 158 | | approval for ninety percent (90%) or more of the healthcare provider's prior 35 |
---|
160 | 159 | | authorization requests based on a review of the healthcare provider' s 36 As Engrossed: H3/6/23 H3/9/23 S3/16/23 HB1271 |
---|
161 | 160 | | |
---|
162 | 161 | | 5 03-16-2023 15:14:00 ANS167 |
---|
163 | 162 | | |
---|
164 | 163 | | |
---|
165 | 164 | | utilization of the particular healthcare services from January 1, 2022, 1 |
---|
166 | 165 | | through June 30, 2022, shall not be required to obtain prior authorization 2 |
---|
167 | 166 | | for a particular healthcare service and shall be considered exempt from prior 3 |
---|
168 | 167 | | authorization requirements th rough September 30, 2024. 4 |
---|
169 | 168 | | (2) If a healthcare provider's use for a particular healthcare 5 |
---|
170 | 169 | | service increases by twenty -five percent (25%) or more during the period 6 |
---|
171 | 170 | | between January 1, 2024, and June 30, 2024, based on a review of the 7 |
---|
172 | 171 | | healthcare provider's utilization of the particular healthcare service from 8 |
---|
173 | 172 | | January 1, 2022, through June 30, 2022, then the healthcare insurer may 9 |
---|
174 | 173 | | disallow the exemption from prior authorization requirements for the 10 |
---|
175 | 174 | | healthcare provider for the particular healthcare service. 11 |
---|
176 | 175 | | (b)(1) A healthcare insurer shall conduct an evaluation of the initial 12 |
---|
177 | 176 | | six-month exemption period based on claims submitted between January 1, 2024, 13 |
---|
178 | 177 | | through June 30, 2024, to determine whether to grant or deny an exemption for 14 |
---|
179 | 178 | | each particular healthcare service that requires a prior authorization by the 15 |
---|
180 | 179 | | healthcare insurer. 16 |
---|
181 | 180 | | (2) The evaluation by the healthcare insurer shall be conducted 17 |
---|
182 | 181 | | by using the retrospective review process under § 23 -99-1122(c) and applying 18 |
---|
183 | 182 | | the criteria under s ubsection (d) of this section. 19 |
---|
184 | 183 | | (3) A healthcare insurer shall submit to a healthcare provider a 20 |
---|
185 | 184 | | written statement of: 21 |
---|
186 | 185 | | (A) The total number of payable claims submitted by or in 22 |
---|
187 | 186 | | connection with the healthcare provider; and 23 |
---|
188 | 187 | | (B) The total number of denied and approved prior 24 |
---|
189 | 188 | | authorizations between January 1, 2022, through June 30, 2022. 25 |
---|
190 | 189 | | (c)(1) No later than October 1, 2024, a healthcare insurer shall issue 26 |
---|
191 | 190 | | a notice to each healthcare provider that either grants or denies a prior 27 |
---|
192 | 191 | | authorization exemption to the healthcare provider for each particular 28 |
---|
193 | 192 | | healthcare service. 29 |
---|
194 | 193 | | (2) An exemption granted under this subdivision (c)(1) shall be 30 |
---|
195 | 194 | | valid for at least twelve (12) months. 31 |
---|
196 | 195 | | (d) Except as provided under subsection (f) of this section or § 23 -32 |
---|
197 | 196 | | 99-1125, a healthcare insurer that uses a prior authorization process for 33 |
---|
198 | 197 | | healthcare services shall not require a healthcare provider to obtain prior 34 |
---|
199 | 198 | | authorization for a particular health care service that a healthcare provider 35 |
---|
200 | 199 | | has previously been subject to a prior authorization requirement if, in the 36 As Engrossed: H3/6/23 H3/9/23 S3/16/23 HB1271 |
---|
201 | 200 | | |
---|
202 | 201 | | 6 03-16-2023 15:14:00 ANS167 |
---|
203 | 202 | | |
---|
204 | 203 | | |
---|
205 | 204 | | most recent six-month evaluation period as described under subsection (e) of 1 |
---|
206 | 205 | | this section, the healthcare insurer has approved or would have approved no 2 |
---|
207 | 206 | | less than ninety percent (90%) of the prior authorization requests submitted 3 |
---|
208 | 207 | | by the healthcare provider for that particular healthcare service. 4 |
---|
209 | 208 | | (e)(1) Except as provided under subsection (f) of this section, a 5 |
---|
210 | 209 | | healthcare insurer shall evalua te whether or not a healthcare provider 6 |
---|
211 | 210 | | qualifies for an exemption from prior authorization requirements under 7 |
---|
212 | 211 | | subsection (d) of this section one (1) time every twelve (12) months. 8 |
---|
213 | 212 | | (2) The six-month period for the evaluation period described 9 |
---|
214 | 213 | | under subsection (d) of this section shall be any consecutive six (6) month 10 |
---|
215 | 214 | | period during the twelve (12) months following the effective date of the 11 |
---|
216 | 215 | | exemption. 12 |
---|
217 | 216 | | (3) The healthcare insurer shall choose a six -month evaluation 13 |
---|
218 | 217 | | period that allows time for: 14 |
---|
219 | 218 | | (A) The evaluation under subsection (d) of this section; 15 |
---|
220 | 219 | | (B) Notice to the healthcare provider of the decision; and 16 |
---|
221 | 220 | | (C) Appeal of the decision for an independent review to be 17 |
---|
222 | 221 | | completed by the end of the twelve -month period of the exemption. 18 |
---|
223 | 222 | | (f) A healthcare insurer may continue an exemption under subsection 19 |
---|
224 | 223 | | (d) of this section without evaluating whether or not the healthcare provider 20 |
---|
225 | 224 | | qualifies for the exemption under subsection (d) of this section for a 21 |
---|
226 | 225 | | particular evaluation period. 22 |
---|
227 | 226 | | (g) A healthcare provider is not required to request an exemption 23 |
---|
228 | 227 | | under subsection (d) of this section to quality for the exemption. 24 |
---|
229 | 228 | | (h) A healthcare insurer may extend an exemption under subsection (d) 25 |
---|
230 | 229 | | of this section to a group of healthcare providers under the same tax 26 |
---|
231 | 230 | | identification number if: 27 |
---|
232 | 231 | | (1) A healthcare provider with an ownership interest in the 28 |
---|
233 | 232 | | entity to which the tax identification number is assigned does not object; or 29 |
---|
234 | 233 | | (2) The tax identification number is associated with a hospital 30 |
---|
235 | 234 | | licensed in this state and the chief executive officer of the hospital agrees 31 |
---|
236 | 235 | | to the exemption. 32 |
---|
237 | 236 | | 33 |
---|
238 | 237 | | 23-99-1121. Duration of prior authorization exemption. 34 |
---|
239 | 238 | | (a) Unless a prior authorization exemption is continued for a longer 35 |
---|
240 | 239 | | period of time by a healthcare insurer under § 23-99-1120(f), a healthcare 36 As Engrossed: H3/6/23 H3/9/23 S3/16/23 HB1271 |
---|
241 | 240 | | |
---|
242 | 241 | | 7 03-16-2023 15:14:00 ANS167 |
---|
243 | 242 | | |
---|
244 | 243 | | |
---|
245 | 244 | | provider's exemption from prior authorization requirements under § 23-99-1120 1 |
---|
246 | 245 | | remains in effect until the later of: 2 |
---|
247 | 246 | | (1) The thirtieth day after the date the healthcare insurer 3 |
---|
248 | 247 | | notifies the healthcare provider of the healthcare insurer's determination to 4 |
---|
249 | 248 | | rescind the exemption as described under § 23-99-1122, if the healthcare 5 |
---|
250 | 249 | | provider does not appeal the healthcare insurer's determination within thirty 6 |
---|
251 | 250 | | (30) days of notification of the determination; 7 |
---|
252 | 251 | | (2) If the healthcare provider appeals the determination within 8 |
---|
253 | 252 | | thirty (30) days of notification of the determination, the fifth day after 9 |
---|
254 | 253 | | the date an independent review organization affirms the healthcare insurer's 10 |
---|
255 | 254 | | determination to rescind the exemption; or 11 |
---|
256 | 255 | | (3) Twelve (12) months after the effective date of the 12 |
---|
257 | 256 | | exemption. 13 |
---|
258 | 257 | | (b) If a healthcare provider appeals the determination to rescind the 14 |
---|
259 | 258 | | exemption more than thirty (30) days after notification of the determination 15 |
---|
260 | 259 | | and the independent review organization overtu rns the rescission, the 16 |
---|
261 | 260 | | healthcare provider’s exemption is restored the fifth day after the date of 17 |
---|
262 | 261 | | the independent review organization’s decision, and the exemption remains in 18 |
---|
263 | 262 | | effect for twelve (12) months after restoration unless rescinded under § 23 -19 |
---|
264 | 263 | | 99-1122. 20 |
---|
265 | 264 | | (c) If a healthcare insurer does not finalize a rescission 21 |
---|
266 | 265 | | determination as specified in subsection (a) of this section, then the 22 |
---|
267 | 266 | | healthcare provider is considered to have met the criteria under § 23-99-1120 23 |
---|
268 | 267 | | to continue to qualify for the exemption. 24 |
---|
269 | 268 | | (d) A healthcare provider shall not rely on another healthcare 25 |
---|
270 | 269 | | provider’s exemption except when the healthcare provider with an exemption is 26 |
---|
271 | 270 | | the healthcare provider that orders healthcare services that are rendered by 27 |
---|
272 | 271 | | a healthcare provider without an exemption. 28 |
---|
273 | 272 | | 29 |
---|
274 | 273 | | 23-99-1122. Denial or rescission of prior authorization exemption. 30 |
---|
275 | 274 | | (a) A healthcare insurer may rescind an exemption from prior 31 |
---|
276 | 275 | | authorization requirements of a healthcare provider under § 23-99-1120 only 32 |
---|
277 | 276 | | if: 33 |
---|
278 | 277 | | (1) The healthcare insurer makes a determination that, on the 34 |
---|
279 | 278 | | basis of a retrospective review of a random sample of claims selected by the 35 |
---|
280 | 279 | | healthcare insurer during the most recent evaluation period described by § 36 As Engrossed: H3/6/23 H3/9/23 S3/16/23 HB1271 |
---|
281 | 280 | | |
---|
282 | 281 | | 8 03-16-2023 15:14:00 ANS167 |
---|
283 | 282 | | |
---|
284 | 283 | | |
---|
285 | 284 | | 23-99-1120(e), less than ninety percent (90%) of the claims for the 1 |
---|
286 | 285 | | particular healthcare service met the medical necessity criteria that would 2 |
---|
287 | 286 | | have been used by the healthcare insurer when conducting prior authorization 3 |
---|
288 | 287 | | review for the particular healthcare service during the relevant evaluation 4 |
---|
289 | 288 | | period; 5 |
---|
290 | 289 | | (2) The healthcare insurer complies with other applicable 6 |
---|
291 | 290 | | requirements specified in this section, including without limitation: 7 |
---|
292 | 291 | | (A) Notifying the healthcare provider no less than twenty-8 |
---|
293 | 292 | | five (25) days before the proposed rescission is to take effect; and 9 |
---|
294 | 293 | | (B) Providing: 10 |
---|
295 | 294 | | (i) An identification of the healthcare service that 11 |
---|
296 | 295 | | an exemption is being rescinded, the date the notice is issued, and the 12 |
---|
297 | 296 | | effective date of the rescission; 13 |
---|
298 | 297 | | (ii) A plain-language explanation of how the 14 |
---|
299 | 298 | | healthcare provider may appeal and seek an ind ependent review of the 15 |
---|
300 | 299 | | determination, the date the notice is issued, and the company’s address and 16 |
---|
301 | 300 | | contact information for returning the form by mail or email to request an 17 |
---|
302 | 301 | | appeal; 18 |
---|
303 | 302 | | (iii) A statement of the total number of payable 19 |
---|
304 | 303 | | claims submitted by or in connection with the healthcare provider during the 20 |
---|
305 | 304 | | most recent evaluation period that were eligible to be evaluated with respect 21 |
---|
306 | 305 | | to the healthcare service subject to rescission, the number of claims 22 |
---|
307 | 306 | | included in the random sample, and the sample infor mation used to make the 23 |
---|
308 | 307 | | determination, including without limitation: 24 |
---|
309 | 308 | | (a) Identification of each claim included in 25 |
---|
310 | 309 | | the random sample; 26 |
---|
311 | 310 | | (b) The healthcare insurer’s determination of 27 |
---|
312 | 311 | | whether each claim met the healthcare insurer’s screening criteri a; and 28 |
---|
313 | 312 | | (c) For any claim determined to not have met 29 |
---|
314 | 313 | | the healthcare insurer’s screening criteria: 30 |
---|
315 | 314 | | (1) The principal reasons for the 31 |
---|
316 | 315 | | determination that the claim did not meet the healthcare insurer’s screening 32 |
---|
317 | 316 | | criteria, including, if applicable, a statement that the determination was 33 |
---|
318 | 317 | | based on a failure to submit specified medical records; 34 |
---|
319 | 318 | | (2) The clinical basis for the 35 |
---|
320 | 319 | | determination that the claim did not meet the healthcare insurer’s screening 36 As Engrossed: H3/6/23 H3/9/23 S3/16/23 HB1271 |
---|
321 | 320 | | |
---|
322 | 321 | | 9 03-16-2023 15:14:00 ANS167 |
---|
323 | 322 | | |
---|
324 | 323 | | |
---|
325 | 324 | | criteria; 1 |
---|
326 | 325 | | (3) A description of the sou rces of the 2 |
---|
327 | 326 | | screening criteria that were used as guidelines in making the determination; 3 |
---|
328 | 327 | | and 4 |
---|
329 | 328 | | (4) The professional specialty of the 5 |
---|
330 | 329 | | healthcare provider who made the determination; 6 |
---|
331 | 330 | | (iv) A space to be filled out by the healthcare 7 |
---|
332 | 331 | | provider that includes: 8 |
---|
333 | 332 | | (a) The name, address, contact information, 9 |
---|
334 | 333 | | and identification number of the healthcare provider requesting an 10 |
---|
335 | 334 | | independent review; 11 |
---|
336 | 335 | | (b) An indication of whether or not the 12 |
---|
337 | 336 | | healthcare provider is requesting that the entity performing the i ndependent 13 |
---|
338 | 337 | | review examine the same random sample or a different random sample of claims, 14 |
---|
339 | 338 | | if available; and 15 |
---|
340 | 339 | | (c) The date the appeal is being requested; 16 |
---|
341 | 340 | | and 17 |
---|
342 | 341 | | (v) An instruction to the healthcare provider to 18 |
---|
343 | 342 | | return the form to the healthcare insurer before the date the rescission 19 |
---|
344 | 343 | | becomes effective; and 20 |
---|
345 | 344 | | (3) The healthcare provider performs five (5) or fewer of a 21 |
---|
346 | 345 | | particular healthcare service in the most recent six -month evaluation period 22 |
---|
347 | 346 | | under § 23-99-1120(e). 23 |
---|
348 | 347 | | (b) A determination made under subdivision (a)(1) of this section 24 |
---|
349 | 348 | | shall be made by a physician who: 25 |
---|
350 | 349 | | (1) Possesses a current and unrestricted license to practice 26 |
---|
351 | 350 | | medicine in this state; and 27 |
---|
352 | 351 | | (2) Has the same or similar specialty as the healthcare 28 |
---|
353 | 352 | | provider. 29 |
---|
354 | 353 | | (c)(1) A healthcare insu rer that is conducting an evaluation under 30 |
---|
355 | 354 | | subsection (a) of this section to determine whether or not a healthcare 31 |
---|
356 | 355 | | provider still qualifies for a prior authorization exemption may request 32 |
---|
357 | 356 | | medical records and documents required for the retrospective review, limited 33 |
---|
358 | 357 | | to no more than twenty (20) claims for a particular healthcare service. 34 |
---|
359 | 358 | | (2) A healthcare insurer shall provide a healthcare provider at 35 |
---|
360 | 359 | | least thirty (30) days to provide the medical records requested under 36 As Engrossed: H3/6/23 H3/9/23 S3/16/23 HB1271 |
---|
361 | 360 | | |
---|
362 | 361 | | 10 03-16-2023 15:14:00 ANS167 |
---|
363 | 362 | | |
---|
364 | 363 | | |
---|
365 | 364 | | subdivision (c)(1) of this section. 1 |
---|
366 | 365 | | (d) A healthcare insurer may deny an exemption from prior 2 |
---|
367 | 366 | | authorization requirements under § 23-99-1120 only if: 3 |
---|
368 | 367 | | (1) The healthcare provider does not have an exemption at the 4 |
---|
369 | 368 | | time of the relevant evaluation period; and 5 |
---|
370 | 369 | | (2) The healthcare insurer provides the healthcare provider 6 |
---|
371 | 370 | | with: 7 |
---|
372 | 371 | | (A) Actual data for the relevant prior authorization 8 |
---|
373 | 372 | | request evaluation period; and 9 |
---|
374 | 373 | | (B) Detailed information sufficient to demonstrate that 10 |
---|
375 | 374 | | the healthcare provider does not meet the criteria for an exemption from 11 |
---|
376 | 375 | | prior authorization requirements for the particular healthcare service under 12 |
---|
377 | 376 | | § 23-99-1120. 13 |
---|
378 | 377 | | (e) A healthcare insurer shall: 14 |
---|
379 | 378 | | (1) Allow a healthcare provider to designate an email address or 15 |
---|
380 | 379 | | a mailing address for communications regarding exemptions, denials, and 16 |
---|
381 | 380 | | rescissions; 17 |
---|
382 | 381 | | (2) Provide an option for a healthcare provider to submit a 18 |
---|
383 | 382 | | request for an appeal by mail, by email, or by other electronic method; and 19 |
---|
384 | 383 | | (3) Include an explanation of how a healthcare provider may 20 |
---|
385 | 384 | | update his or her preferred contact information and delivery method on the 21 |
---|
386 | 385 | | healthcare insurer's website and for all communications issued under this 22 |
---|
387 | 386 | | section. 23 |
---|
388 | 387 | | 24 |
---|
389 | 388 | | 23-99-1123. Independent review of exemption determination. 25 |
---|
390 | 389 | | (a)(1) A healthcare provider has a right to a review of an adverse 26 |
---|
391 | 390 | | determination regarding a prior authorization exemption within twelve (12) 27 |
---|
392 | 391 | | months of receiving proper notice of recission from a healthcare insurer to 28 |
---|
393 | 392 | | be conducted by an independent review organization. 29 |
---|
394 | 393 | | (2) A healthcare insurer shall not require a healthcare provider 30 |
---|
395 | 394 | | to engage in an internal appeal process before requesting a review by an 31 |
---|
396 | 395 | | independent review organization under this section. 32 |
---|
397 | 396 | | (3) A healthcare provider who has an exemption rescinded due to 33 |
---|
398 | 397 | | a failure to provide medical records within sixty (60) days of a record 34 |
---|
399 | 398 | | request for a retrospective review shall not be eligible for review of that 35 |
---|
400 | 399 | | rescission by an independent review entity. 36 As Engrossed: H3/6/23 H3/9/23 S3/16/23 HB1271 |
---|
401 | 400 | | |
---|
402 | 401 | | 11 03-16-2023 15:14:00 ANS167 |
---|
403 | 402 | | |
---|
404 | 403 | | |
---|
405 | 404 | | (b) A healthcare insurer shall pay: 1 |
---|
406 | 405 | | (1) For any appeal or independent review of an adverse 2 |
---|
407 | 406 | | determination regarding a prior authorization exemption requested under this 3 |
---|
408 | 407 | | section; and 4 |
---|
409 | 408 | | (2) A reasonable fee determined by the Arkansas State Medical 5 |
---|
410 | 409 | | Board for any copies of medical records or other documents requested from a 6 |
---|
411 | 410 | | healthcare provider during an exemption rescission review requested under 7 |
---|
412 | 411 | | this section. 8 |
---|
413 | 412 | | (c) An independent review organization shall complete an expedited 9 |
---|
414 | 413 | | review of an adverse determination regarding a prior authorization exemption 10 |
---|
415 | 414 | | no later than the thirtieth day after the date a healthcare provider files 11 |
---|
416 | 415 | | the request for a review under this section. 12 |
---|
417 | 416 | | (d)(1) A healthcare provider may request that the independent review 13 |
---|
418 | 417 | | organization consider another random sample of no fewer than five (5) and no 14 |
---|
419 | 418 | | more than twenty (20) claims submitted to the healthcare insurer by the 15 |
---|
420 | 419 | | healthcare provider during the relevant evaluation period for the relevant 16 |
---|
421 | 420 | | healthcare service as part of the review under this section. 17 |
---|
422 | 421 | | (2) If a healthcare provider makes a request under subdivision 18 |
---|
423 | 422 | | (d)(1) of this section, the independent review organization shall base its 19 |
---|
424 | 423 | | determination on the medical necessity of claims reviewed: 20 |
---|
425 | 424 | | (A) By the healthcare insurer under § 23-99-1122; and 21 |
---|
426 | 425 | | (B) By the independent review organization under 22 |
---|
427 | 426 | | subdivision (d)(1) of this section. 23 |
---|
428 | 427 | | (e) The Insurance Commissioner may refuse, suspend, revoke, or not 24 |
---|
429 | 428 | | renew a license or certificate of authority of a healthcare insurer that has 25 |
---|
430 | 429 | | fifty percent (50%) of healthcare provider appeals overturned in a twelve -26 |
---|
431 | 430 | | month period by an independent review organization under this section. 27 |
---|
432 | 431 | | 28 |
---|
433 | 432 | | 23-99-1124. Effect of appeal of independent review organization 29 |
---|
434 | 433 | | determination. 30 |
---|
435 | 434 | | (a) A healthcare insurer is bound by an appeal or independent review 31 |
---|
436 | 435 | | organization determination that does not affirm the determination made by the 32 |
---|
437 | 436 | | healthcare insurer to rescind a prior authorization exemption. 33 |
---|
438 | 437 | | (b) A healthcare insurer shall not retroactively deny a healthcare 34 |
---|
439 | 438 | | service on the basis of a rescission of an exemption, even if the healthcare 35 |
---|
440 | 439 | | insurer's determination to rescind the prior authorization exemption is 36 As Engrossed: H3/6/23 H3/9/23 S3/16/23 HB1271 |
---|
441 | 440 | | |
---|
442 | 441 | | 12 03-16-2023 15:14:00 ANS167 |
---|
443 | 442 | | |
---|
444 | 443 | | |
---|
445 | 444 | | affirmed by an independent review organization. 1 |
---|
446 | 445 | | (c) If a determination of a prior authorization exemption made by the 2 |
---|
447 | 446 | | healthcare insurer is overturned on review by an independent review 3 |
---|
448 | 447 | | organization, the healthcare insurer: 4 |
---|
449 | 448 | | (1) Shall not attempt to rescind the exemption before the end of 5 |
---|
450 | 449 | | the next evaluation period; and 6 |
---|
451 | 450 | | (2) May only rescind the exemption if the healthcare insurer 7 |
---|
452 | 451 | | complies with §§ 23-99-1122 and 23-99-1123. 8 |
---|
453 | 452 | | 9 |
---|
454 | 453 | | 23-99-1125. Eligibility for prior authorization exemption following 10 |
---|
455 | 454 | | finalized exemption rescission or denial. 11 |
---|
456 | 455 | | (a) After a final determination or review affirming the rescission or 12 |
---|
457 | 456 | | denial of an exemption for a specific healthcare service under § 23-99-1120, 13 |
---|
458 | 457 | | a healthcare insurer shall conduct another evaluation to determine whether or 14 |
---|
459 | 458 | | not the exemption should be granted or reinstated based on the six-month 15 |
---|
460 | 459 | | evaluation period that follows the evaluation period that formed the basis of 16 |
---|
461 | 460 | | the rescission or denial of an exemption. 17 |
---|
462 | 461 | | (b) A time period that is included in a previous evaluation or 18 |
---|
463 | 462 | | determination period shall not be included in a subsequent evaluation period. 19 |
---|
464 | 463 | | 20 |
---|
465 | 464 | | 23-99-1126. Effect of prior authorization exemption. 21 |
---|
466 | 465 | | (a) A healthcare insurer shall not deny or reduce payment to a 22 |
---|
467 | 466 | | healthcare provider for a healthcare service for which the healthcare 23 |
---|
468 | 467 | | provider has qualified for an exemption from prior authorization requirements 24 |
---|
469 | 468 | | under § 23-99-1120, including a healthcare service performed or supervised by 25 |
---|
470 | 469 | | another healthcare provider, if the health care provider who ordered the 26 |
---|
471 | 470 | | healthcare service received a prior authorization exemption based on medical 27 |
---|
472 | 471 | | necessity or appropriateness of care unless the healthcare provider: 28 |
---|
473 | 472 | | (1) Knowingly and materially misrepresented the healthcare 29 |
---|
474 | 473 | | service in a request for payment submitted to the healthcare insurer with the 30 |
---|
475 | 474 | | specific intent to deceive the healthcare insurer and obtain an unlawful 31 |
---|
476 | 475 | | payment from the healthcare insurer; or 32 |
---|
477 | 476 | | (2) Substantially failed to perform the healthcare service. 33 |
---|
478 | 477 | | (b) A healthcare insurer shall not conduct a retrospective review of a 34 |
---|
479 | 478 | | healthcare service subject to an exemption except: 35 |
---|
480 | 479 | | (1) To determine if the healthcare provider still qualifies for 36 As Engrossed: H3/6/23 H3/9/23 S3/16/23 HB1271 |
---|
481 | 480 | | |
---|
482 | 481 | | 13 03-16-2023 15:14:00 ANS167 |
---|
483 | 482 | | |
---|
484 | 483 | | |
---|
485 | 484 | | an exemption under § 23 -99-1120; or 1 |
---|
486 | 485 | | (2) If the healthcare insurer has a reaso nable cause to suspect 2 |
---|
487 | 486 | | a basis for denial exists under subsection (a) of this section. 3 |
---|
488 | 487 | | (c) For a retrospective review described by subdivision (b)(2) of this 4 |
---|
489 | 488 | | section, §§ 23-99-1120 — 23-99-1125 shall not modify or otherwise affect: 5 |
---|
490 | 489 | | (1) The requirements under or application of § 23-99-1115, 6 |
---|
491 | 490 | | including without limitation any time frames; or 7 |
---|
492 | 491 | | (2) Any other applicable law, except to prescribe the only 8 |
---|
493 | 492 | | circumstances under which: 9 |
---|
494 | 493 | | (A) A retrospective review may occur as specified by 10 |
---|
495 | 494 | | subdivision (b)(2) of this section; or 11 |
---|
496 | 495 | | (B) Payment may be denied or reduced as specified by 12 |
---|
497 | 496 | | subsection (a) of this section. 13 |
---|
498 | 497 | | (d) Beginning on January 1, 2024, a healthcare insurer shall provide 14 |
---|
499 | 498 | | to a healthcare provider a notice that includes a: 15 |
---|
500 | 499 | | (1) Statement that the healthcare provider has an exemption from 16 |
---|
501 | 500 | | prior authorization requirements under § 23-99-1120; 17 |
---|
502 | 501 | | (2) List of the healthcare services and health benefit plans to 18 |
---|
503 | 502 | | which the exemption applies; and 19 |
---|
504 | 503 | | (3) Statement of the duration of the exemption. 20 |
---|
505 | 504 | | (e) If a healthcare provider submits a prior authorization request for 21 |
---|
506 | 505 | | a healthcare service for which the healthcare provider has an exemption from 22 |
---|
507 | 506 | | prior authorization requirements under § 23-99-1120, the healthcare insurer 23 |
---|
508 | 507 | | shall promptly provide a notice to the healthcare provider that includes: 24 |
---|
509 | 508 | | (1) The information described in subsection (d) of this section; 25 |
---|
510 | 509 | | and 26 |
---|
511 | 510 | | (2) A notification of the healthcare insurer's payment 27 |
---|
512 | 511 | | requirements. 28 |
---|
513 | 512 | | (f) This section and §§ 23-99-1120 — 23-99-1125 shall not be construed 29 |
---|
514 | 513 | | to: 30 |
---|
515 | 514 | | (1) Authorize a healthcare provider to provide a healthcare 31 |
---|
516 | 515 | | service outside the scope of the healthcare provider's applicable license; or 32 |
---|
517 | 516 | | (2) Require a healthcare insurer to pay for a healthcare service 33 |
---|
518 | 517 | | described by subdivision (f)(1) of this section that is performed in 34 |
---|
519 | 518 | | violation of the laws of this state. 35 |
---|
520 | 519 | | (g) A healthcare insurer that offers multiple health benefit plans or 36 As Engrossed: H3/6/23 H3/9/23 S3/16/23 HB1271 |
---|
521 | 520 | | |
---|
522 | 521 | | 14 03-16-2023 15:14:00 ANS167 |
---|
523 | 522 | | |
---|
524 | 523 | | |
---|
525 | 524 | | that utilizes multiple healthcare provider networks shall not determine a 1 |
---|
526 | 525 | | healthcare provider’s eligibility for an exemption fr om prior authorization 2 |
---|
527 | 526 | | for each specific health benefit plan or each specific healthcare provider 3 |
---|
528 | 527 | | network but rather shall determine the healthcare provider’s eligibility for 4 |
---|
529 | 528 | | an exemption applicable to all health benefit plans and healthcare provider 5 |
---|
530 | 529 | | networks. 6 |
---|
531 | 530 | | (h) If a healthcare insurer and a healthcare provider are engaged in a 7 |
---|
532 | 531 | | value-based reimbursement arrangement for particular healthcare services or 8 |
---|
533 | 532 | | subscribers, the healthcare insurer shall not impose any prior authorization 9 |
---|
534 | 533 | | requirements for any part icular healthcare service that is included in that 10 |
---|
535 | 534 | | value-based reimbursement arrangement. 11 |
---|
536 | 535 | | 12 |
---|
537 | 536 | | 23-99-1127. Applicability. 13 |
---|
538 | 537 | | (a)(1) An organization or entity directly or indirectly providing a 14 |
---|
539 | 538 | | plan or services to patients under the Medicaid Provider -Led Organized Care 15 |
---|
540 | 539 | | Act, § 20-77-2701 et seq., or any other Medicaid -managed care program 16 |
---|
541 | 540 | | operating in this state is exempt from §§ 23 -99-1120 – 23-99-1126 if the 17 |
---|
542 | 541 | | program, without limiting the program's application to any other plan or 18 |
---|
543 | 542 | | program, develops a program to reduce or eliminate prior authorizations for a 19 |
---|
544 | 543 | | healthcare provider on or before January 1, 2025. 20 |
---|
545 | 544 | | (2) The Arkansas Health and Opportunity for Me Program established by 21 |
---|
546 | 545 | | the Arkansas Health and Opportunity for Me Act of 2021, § 23 -61-1001 et seq., 22 |
---|
547 | 546 | | or its successor program is exempt from §§ 23 -99-1120 – 23-99-1126, provided 23 |
---|
548 | 547 | | that the Arkansas Health and Opportuni ty for Me Program, without limiting the 24 |
---|
549 | 548 | | Arkansas Health and Opportunity for Me Program's application to any other 25 |
---|
550 | 549 | | plan or program, develops a program to reduce or eliminate prior 26 |
---|
551 | 550 | | authorizations for a healthcare provider on or before January 1, 2025. 27 |
---|
552 | 551 | | (3) A qualified health plan that is a health benefit plan under 28 |
---|
553 | 552 | | the Patient Protection and Affordable Care Act, Pub. L. No. 111 -148, and 29 |
---|
554 | 553 | | purchased on the Arkansas Health Insurance Marketplace created under the 30 |
---|
555 | 554 | | Arkansas Health Insurance Marketplace Act, § 23-61-801 et seq., for an 31 |
---|
556 | 555 | | individual up to four hundred percent (400%) of the federal poverty level, 32 |
---|
557 | 556 | | operating in this state is exempt from §§ 23-99-1120 — 23-99-1126 if the 33 |
---|
558 | 557 | | qualified health plan, without limiting the program's application to any 34 |
---|
559 | 558 | | other plan or program, develops a program to reduce or eliminate prior 35 |
---|
560 | 559 | | authorizations for a healthcare provider on or before January 1, 2025. 36 As Engrossed: H3/6/23 H3/9/23 S3/16/23 HB1271 |
---|
561 | 560 | | |
---|
562 | 561 | | 15 03-16-2023 15:14:00 ANS167 |
---|
563 | 562 | | |
---|
564 | 563 | | |
---|
565 | 564 | | (b)(1) The programs under subsection (a) of this section to reduce or 1 |
---|
566 | 565 | | eliminate prior authorization shall be: 2 |
---|
567 | 566 | | (A) Submitted to the State Insurance Department; and 3 |
---|
568 | 567 | | (B) Subject to approval by the Legislative Council. 4 |
---|
569 | 568 | | (2) If a program is not submitted to the department and approved 5 |
---|
570 | 569 | | by the Legislative Council on or before January 1, 2025, the Medicaid -managed 6 |
---|
571 | 570 | | care program operating in this state, the Arkansas Health and Opportunity for 7 |
---|
572 | 571 | | Me Program established by the Arkansas Health and Opportunity for Me Act of 8 |
---|
573 | 572 | | 2021, § 23-61-1001 et seq., or its successor program, and qualified health 9 |
---|
574 | 573 | | plans under the Patient Protection and Affordable Care Act, Pub. L. No. 111 -10 |
---|
575 | 574 | | 148, and purchased on the Arkansas Health Insurance Marketplace created under 11 |
---|
576 | 575 | | the Arkansas Health Insurance Marketplace Act, § 23-61-801 et seq., for an 12 |
---|
577 | 576 | | individual up to four hundred percent (400%) of the federal povert y level, 13 |
---|
578 | 577 | | operating in this state shall be subject to §§ 23 -99-1120 – 23-99-1126 and § 14 |
---|
579 | 578 | | 23-99-1128 as of January 1, 2025. 15 |
---|
580 | 579 | | (c) Any state or local governmental employee plan is exempt from §§ 16 |
---|
581 | 580 | | 23-99-1120 — 23-99-1126 and § 23-99-1128. 17 |
---|
582 | 581 | | (d) A health benefit p lan provided by a trust established under §§ 14 -18 |
---|
583 | 582 | | 54-101 and 25-20-104 to provide benefits, including accident and health 19 |
---|
584 | 583 | | benefits, death benefits, dental benefits, and disability income benefits, is 20 |
---|
585 | 584 | | exempt from §§ 23-99-1120 – 23-99-1126. 21 |
---|
586 | 585 | | (e)(1) Prescription drugs, medicines, biological products, 22 |
---|
587 | 586 | | pharmaceuticals, or pharmaceutical services are exempt as a healthcare 23 |
---|
588 | 587 | | service for purposes of §§ 23 -99-1120 – 23-99-1126 until December 31, 2024. 24 |
---|
589 | 588 | | (2)(A) As of January 1, 2025, the provisions of §§ 23 -99-1120 – 25 |
---|
590 | 589 | | 23-99-1126 shall apply to prescription drugs, medicines, biological products, 26 |
---|
591 | 590 | | pharmaceuticals, or pharmaceutical services that have not been approved for 27 |
---|
592 | 591 | | continuation of prior authorization under § 23 -99-1128. 28 |
---|
593 | 592 | | (B) For the products in subdivision (e)(2)(A) of this 29 |
---|
594 | 593 | | section that have not been approved for continuation of prior authorization, 30 |
---|
595 | 594 | | for purposes of § 23 -99-1120, then: 31 |
---|
596 | 595 | | (i) Provisions regarding time periods specified 32 |
---|
597 | 596 | | during the calendar year 2022 shall instead apply to the same months dur ing 33 |
---|
598 | 597 | | calendar year 2023; and 34 |
---|
599 | 598 | | (ii) Provisions regarding time periods specified 35 |
---|
600 | 599 | | during the calendar year 2024 shall instead apply to the same months during 36 As Engrossed: H3/6/23 H3/9/23 S3/16/23 HB1271 |
---|
601 | 600 | | |
---|
602 | 601 | | 16 03-16-2023 15:14:00 ANS167 |
---|
603 | 602 | | |
---|
604 | 603 | | |
---|
605 | 604 | | calendar year 2025. 1 |
---|
606 | 605 | | 2 |
---|
607 | 606 | | 23-99-1128. Prescription drugs, medicines, biological products, 3 |
---|
608 | 607 | | pharmaceuticals, or pharmaceutical services. 4 |
---|
609 | 608 | | (a)(1) Beginning on January 1, 2024, a healthcare insurer or pharmacy 5 |
---|
610 | 609 | | benefits manager shall submit a written request to the Arkansas State Board 6 |
---|
611 | 610 | | of Pharmacy for any prescription drug, medicine, biological product, 7 |
---|
612 | 611 | | pharmaceutical, or pharmaceutical service to be reviewed for a continuation 8 |
---|
613 | 612 | | of prior authorization by a specified health benefit plan whether or not a 9 |
---|
614 | 613 | | healthcare provider has met the criteria for an exemption from prior 10 |
---|
615 | 614 | | authorization under §§ 23 -99-1120 – 23-99-1126. 11 |
---|
616 | 615 | | (2) The request under subdivision (a)(1) of this section shall 12 |
---|
617 | 616 | | state the reason the request is being made for each prescription drug, 13 |
---|
618 | 617 | | medicine, biological product, pharmaceutical, or pharmaceutical service for 14 |
---|
619 | 618 | | the specified health benefit plan. 15 |
---|
620 | 619 | | (b) The Arkansas State Board of Pharmacy and the Arkansas State 16 |
---|
621 | 620 | | Medical Board, jointly, may establish criteria and procedures to review 17 |
---|
622 | 621 | | whether a request made under subdivision (a)(1) of this section should be 18 |
---|
623 | 622 | | granted for the requesting party and specifi ed health benefit plan. 19 |
---|
624 | 623 | | (c)(1) The Arkansas State Board of Pharmacy and the Arkansas State 20 |
---|
625 | 624 | | Medical Board, jointly, may determine whether or not a prescription drug, 21 |
---|
626 | 625 | | medicine, biological product, pharmaceutical, or pharmaceutical service may 22 |
---|
627 | 626 | | be subject to prior authorization by a health benefit plan under the criteria 23 |
---|
628 | 627 | | and procedures under subsection (b) of this section. 24 |
---|
629 | 628 | | (2) The Arkansas State Board of Pharmacy shall promptly notify 25 |
---|
630 | 629 | | the entity that made the request of the joint decision made by the Arkan sas 26 |
---|
631 | 630 | | State Board of Pharmacy and the Arkansas State Medical Board. 27 |
---|
632 | 631 | | (d) The Arkansas State Board of Pharmacy shall make available to any 28 |
---|
633 | 632 | | person who requests it, a list for any health benefit plan of prescription 29 |
---|
634 | 633 | | drugs, medicines, biological products, pharmaceuticals, or pharmaceutical 30 |
---|
635 | 634 | | services that require a prior authorization under this section. 31 |
---|
636 | 635 | | 32 |
---|
637 | 636 | | 23-99-1129. Appeals process for disallowance of prior authorization. 33 |
---|
638 | 637 | | (a) If the Arkansas State Board of Pharmacy and the Arkansas State 34 |
---|
639 | 638 | | Medical Board, jointly, disallow a prior authorization of a prescription 35 |
---|
640 | 639 | | drug, medicine, biological product, pharmaceutical, or pharmaceutical service 36 As Engrossed: H3/6/23 H3/9/23 S3/16/23 HB1271 |
---|
641 | 640 | | |
---|
642 | 641 | | 17 03-16-2023 15:14:00 ANS167 |
---|
643 | 642 | | |
---|
644 | 643 | | |
---|
645 | 644 | | requested under § 23 -99-1128, a healthcare insurer, pharmacy benefits 1 |
---|
646 | 645 | | manager, or other interested party may file an app eal to the State Insurance 2 |
---|
647 | 646 | | Department within ninety (90) days of the disallowance of the prior 3 |
---|
648 | 647 | | authorization. 4 |
---|
649 | 648 | | (b) No later than the thirtieth day after the date a healthcare 5 |
---|
650 | 649 | | insurer, pharmacy benefits manager, or other interested party files an appeal 6 |
---|
651 | 650 | | under subsection (a) of this section, the Insurance Commissioner shall 7 |
---|
652 | 651 | | appoint an independent review organization to review the appeal. 8 |
---|
653 | 652 | | (c) A healthcare insurer, pharmacy benefits manager, or other 9 |
---|
654 | 653 | | interested party that files an appeal under subsection (a) of this section 10 |
---|
655 | 654 | | shall pay for the independent review organization appointed under subsection 11 |
---|
656 | 655 | | (b) of this section to review the appeal. 12 |
---|
657 | 656 | | (d) A healthcare insurer, pharmacy benefits manager, or other 13 |
---|
658 | 657 | | interested party is bound by the independent review organization's 14 |
---|
659 | 658 | | determination of the appeal under this section. 15 |
---|
660 | 659 | | 16 |
---|
661 | 660 | | /s/L. Johnson 17 |
---|
662 | 661 | | 18 |
---|
663 | 662 | | 19 |
---|